Miracle Mile Advisors LLC increased its position in Oracle Co. (NYSE:ORCL – Free Report) by 1.9% during the 1st quarter, Holdings Channel.com reports. The firm owned 14,364 shares of the enterprise software provider’s stock after purchasing an additional 271 shares during the period. Miracle Mile Advisors LLC’s holdings in Oracle were worth $1,804,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in ORCL. Invst LLC lifted its stake in shares of Oracle by 2.7% during the 4th quarter. Invst LLC now owns 3,299 shares of the enterprise software provider’s stock worth $380,000 after acquiring an additional 86 shares during the last quarter. Nemes Rush Group LLC lifted its stake in shares of Oracle by 1.2% during the 4th quarter. Nemes Rush Group LLC now owns 7,334 shares of the enterprise software provider’s stock worth $773,000 after acquiring an additional 86 shares during the last quarter. Avidian Wealth Solutions LLC lifted its stake in shares of Oracle by 1.1% during the 4th quarter. Avidian Wealth Solutions LLC now owns 8,516 shares of the enterprise software provider’s stock worth $898,000 after acquiring an additional 90 shares during the last quarter. Sovereign Financial Group Inc. lifted its stake in shares of Oracle by 2.9% during the 4th quarter. Sovereign Financial Group Inc. now owns 3,244 shares of the enterprise software provider’s stock worth $342,000 after acquiring an additional 90 shares during the last quarter. Finally, Godshalk Welsh Capital Management Inc. lifted its stake in shares of Oracle by 0.3% during the 4th quarter. Godshalk Welsh Capital Management Inc. now owns 33,435 shares of the enterprise software provider’s stock worth $3,525,000 after acquiring an additional 90 shares during the last quarter. 42.44% of the stock is owned by hedge funds and other institutional investors.
Oracle Stock Performance
NYSE ORCL opened at $143.09 on Tuesday. The stock has a market capitalization of $394.34 billion, a price-to-earnings ratio of 38.57, a PEG ratio of 2.56 and a beta of 1.02. Oracle Co. has a twelve month low of $99.26 and a twelve month high of $145.32. The company has a current ratio of 0.71, a quick ratio of 0.72 and a debt-to-equity ratio of 8.25. The stock has a 50-day moving average of $125.24 and a 200 day moving average of $118.19.
Oracle Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Thursday, July 25th. Investors of record on Thursday, July 11th will be issued a $0.40 dividend. The ex-dividend date is Thursday, July 11th. This represents a $1.60 dividend on an annualized basis and a yield of 1.12%. Oracle’s payout ratio is 43.13%.
Analyst Ratings Changes
A number of brokerages have weighed in on ORCL. Mizuho lifted their target price on Oracle from $160.00 to $170.00 and gave the company a “buy” rating in a research report on Monday, June 17th. Argus lifted their target price on Oracle from $145.00 to $159.00 and gave the company a “buy” rating in a research report on Tuesday, June 18th. BMO Capital Markets lifted their target price on Oracle from $142.00 to $160.00 and gave the company a “market perform” rating in a research report on Monday, June 17th. William Blair raised Oracle from a “market perform” rating to an “outperform” rating in a research report on Tuesday, March 12th. Finally, Citigroup reduced their price target on Oracle from $133.00 to $128.00 and set a “neutral” rating for the company in a research report on Monday, June 10th. Fourteen analysts have rated the stock with a hold rating and seventeen have given a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $145.83.
Check Out Our Latest Analysis on Oracle
Insider Buying and Selling
In other Oracle news, insider Edward Screven sold 37,221 shares of the stock in a transaction that occurred on Wednesday, June 26th. The stock was sold at an average price of $140.19, for a total transaction of $5,218,011.99. Following the completion of the transaction, the insider now owns 2,626,764 shares of the company’s stock, valued at $368,246,045.16. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In other Oracle news, insider Edward Screven sold 37,221 shares of the stock in a transaction that occurred on Wednesday, June 26th. The stock was sold at an average price of $140.19, for a total transaction of $5,218,011.99. Following the completion of the transaction, the insider now owns 2,626,764 shares of the company’s stock, valued at $368,246,045.16. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director George H. Conrades sold 20,000 shares of the stock in a transaction that occurred on Friday, May 3rd. The shares were sold at an average price of $116.00, for a total value of $2,320,000.00. Following the transaction, the director now directly owns 17,836 shares of the company’s stock, valued at approximately $2,068,976. The disclosure for this sale can be found here. In the last 90 days, insiders sold 385,639 shares of company stock valued at $53,002,729. 42.80% of the stock is owned by company insiders.
Oracle Company Profile
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
Featured Stories
- Five stocks we like better than Oracle
- What is a Special Dividend?
- Snowflake Stock Rebounds, Flies Higher on AI Spending
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Complete Solaria, Senti, and POET: 3 High Volume Penny Stocks
- What is a SEC Filing?
- Pfizer Stock is Ready to Stage a Turnaround on GLP-1 Hopes
Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Co. (NYSE:ORCL – Free Report).
Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.